Jyothi Gudla, MD
Geriatric Medicine · Canton, OHNPI 1194872713
Payments from drug & device makers
Across 427 payments — averaging $14.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Acadia Pharmaceuticals Inc$1K
- Neurocrine Biosciences, Inc.$529
- Eisai Inc.$292
- Avanir Pharmaceuticals, Inc.$287
- Astellas Pharma US Inc$270
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,83797%
- Education$2113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 107 | $1,554 |
| Acadia Pharmaceuticals Inc | 86 | $1,200 |
| Neurocrine Biosciences, Inc. | 58 | $529 |
| Eisai Inc. | 16 | $292 |
| Avanir Pharmaceuticals, Inc. | 20 | $287 |
| Astellas Pharma US Inc | 15 | $270 |
| Novartis | 17 | $231 |
| Sunovion Pharmaceuticals Inc. | 13 | $178 |
| Vanda Pharmaceuticals Inc. | 11 | $177 |
| Otsuka America Pharmaceutical, Inc. | 9 | $149 |
| AstraZeneca | 10 | $147 |
| Lilly USA, LLC | 9 | $139 |
| Sumitomo Pharma America, Inc. | 9 | $99 |
| Insmed, Inc. | 4 | $87 |
| Johnson & Johnson | 6 | $82 |
| Boston Scientific | 2 | $75 |
| Lundbeck LLC | 4 | $59 |
| AbbVie | 3 | $56 |
| SK Life Science, Inc. | 3 | $49 |
| Merck | 3 | $42 |
| Neurelis, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Melinta Therapeutics, LLC | 2 | $35 |
| Bayer | 2 | $29 |
| Urovant Sciences Inc | 2 | $27 |
| Abbott | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $19 |
| CMP Pharma, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Biogen | 1 | $15 |
| Mannkind Corporation | 1 | $14 |
| Amgen | 1 | $14 |
| Pfizer | 1 | $14 |
| Optinose US, Inc. | 1 | $14 |
| UCB, Inc. | 1 | $13 |
| Ardelyx, Inc. | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $11 |
How this compares
$6,048 in reported general payments places this provider in the 90th percentile of 146 geriatric medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,299 | $448,085 |
| TrulicityDulaglutide | 319 | $285,455 |
| AustedoDeutetrabenazine | 48 | $222,655 |
| NuplazidPimavanserin Tartrate | 54 | $199,164 |
| Austedo XrDeutetrabenazine | 37 | $149,259 |
| JardianceEmpagliflozin | 389 | $140,148 |
| IngrezzaValbenazine Tosylate | 16 | $131,311 |
| XareltoRivaroxaban | 321 | $113,196 |
| Invega SustennaPaliperidone Palmitate | 29 | $97,702 |
| MyrbetriqMirabegron | 292 | $80,742 |
| NuedextaDextromethorphan Hbr/Quinidine | 84 | $76,231 |
| TradjentaLinagliptin | 234 | $70,547 |
| GemtesaVibegron | 176 | $67,754 |
| Bydureon BciseExenatide Microspheres | 75 | $67,113 |
| OzempicSemaglutide | 62 | $63,712 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $448,0851,299 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $1,554 | $371,91485 claims |
| Lilly USA, LLCTrulicity | $139 | $285,455319 claims |
| Johnson & JohnsonXarelto, Invega Sustenna | $82 | $210,898350 claims |
| Acadia Pharmaceuticals IncNuplazid | $1,200 | $199,16454 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $529 | $131,31116 claims |
| AbbVieLinzess, Vraylar, Ubrelvy | $56 | $88,876118 claims |
| Astellas Pharma US IncMyrbetriq | $270 | $80,742292 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $287 | $76,23184 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $149 | $68,92753 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $99 | $67,754176 claims |
| NovartisEntresto | $231 | $56,906133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 146 geriatric medicine providers in Ohio.
Other geriatric medicine in Canton
- Babak TousiCleveland$8.6M
- Meenakshi PatelCenterville$3.9M
- Robert KeyesCincinnati$624K
- Daniel CannoneWadsworth$423K
- James FidelholtzCincinnati$392K
- Brinder VijWest Chester$92K
- Sean CannoneCopley$74K
- Andrew GrubbsCincinnati$52K
- Tai-Chi KwokWooster$26K
- Rodney IsonCanal Fulton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.